Prospects for Minocycline Neuroprotection
- 1 December 2010
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 67 (12), 1442-1448
- https://doi.org/10.1001/archneurol.2010.191
Abstract
Minocycline is a clinically available antibiotic and anti-inflammatory drug that also demonstrates neuroprotective properties in a variety of experimental models of neurological diseases. There have thus far been more than 300 publications on minocycline neuroprotection, including a growing number of human studies. Our objective is to critically review the biological basis and translational potential of this action of minocycline on the nervous system.Keywords
This publication has 39 references indexed in Scilit:
- Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channelsJournal of Bioenergetics and Biomembranes, 2010
- Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic strokeBMC Neuroscience, 2009
- Minocycline and neurodegenerative diseasesBehavioural Brain Research, 2009
- Interactions with GluR1 AMPA receptors could influence the therapeutic usefulness of minocycline in ALSAmyotrophic Lateral Sclerosis, 2009
- Minocycline treatment following hypoxicischaemic injury attenuates white matter injury in a rodent model of periventricular leucomalaciaNeuropathology and Applied Neurobiology, 2008
- The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot studyMultiple Sclerosis Journal, 2007
- Chronic Treatment With Minocycline Preserves Adult New Neurons and Reduces Functional Impairment After Focal Cerebral IschemiaStroke, 2007
- Nigrostriatal Dopaminergic Neurodegeneration in theWeaverMouse Is Mediated via Neuroinflammation and Alleviated by Minocycline AdministrationJournal of Neuroscience, 2006
- Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrationsProceedings of the National Academy of Sciences of the United States of America, 2006
- Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's diseaseEuropean Journal of Neuroscience, 2004